Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Biomedical Materials Research

• Publication date

  1999-06-05

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1002/(SICI)1097-4636(19990605)45:3<175::AID-JBM3>3.0.CO;2-9PMID 10397973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.

  1998cited by this paper
• Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis.

  1997cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules*

  1997cited by this paper
• Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium.

  1997cited by this paper
• Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.

  1996cited by this paper
• Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

  1996cited by this paper
• Periprosthetic bone resorption. Particles versus movement.

  1996cited by this paper
• The recombinant catalytic domain of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP‐2

  1996cited by this paper
• Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation

  1996cited by this paper
• Biochemical Characterization of Human Collagenase-3 (*)

  1996cited by this paper
• Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses.

  1995cited by this paper
• Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris.

  1995cited by this paper
• Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*)

  1995cited by this paper
• Extracellular matrix metalloproteinases around loose total hip prostheses.

  1994cited by this paper
• Gelatinase/type IV collagenases in the loosening of total hip replacement endoprostheses.

  1994cited by this paper
• Adsorption of collagenase to particulate titanium: a possible mechanism for collagenase localization in periprosthetic tissue.

  1994cited by this paper
• Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies.

  1994cited by this paper
• Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies.

  1993cited by this paper
• Cemented versus cementless hip arthroplasty. A review of prosthetic biocompatibility.

  1992cited by this paper
• Prostaglandin E2 production by the membrane surrounding loose and fixated cemented tibial hemiarthroplasties in the rabbit knee.

  1992cited by this paper
• Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

  1992cited by this paper
• The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

  1991cited by this paper
• Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.

  1991cited by this paper
• Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma.

  1990cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.

  1986cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Extensive localized bone resorption in the femur following total hip replacement.

  1976cited by this paper
• The pathogenesis of osteoarthritis.

  1976cited by this paper

• Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases‐2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses

  2013cites this paper
• Wear and corrosion in the loosening of total joint replacements (TJRs)

  2013cites this paper
• Bovine chronic osteoarthritis causes minimal change in synovial fluid.

  2013cites this paper
• MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.

  2012cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE ODONTOLOGIA DE RIBEIRÃO PRETO

  2012cites this paper
• Análisis de partículas de desgaste en tejido periprotésico de cadera y rodilla con microscopia electrónica de barrido

  2012cites this paper
• Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants

  2012cites this paper
• Evaluation of In Vivo Proteolytic Activity

  2012cites this paper
• Polyethylene wear particles do not induce inflammation or gelatinase (MMP-2 and MMP-9) activity in fibrous tissue interfaces of loosening total hip arthroplasties.

  2011cites this paper
• Le potentiel thérapeutique du GDF-5 dans l’arthrose : une étude in vitro des facteurs anaboliques et cataboliques du cartilage

  2010cites this paper
• [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts].

  2010cites this paper
• Bone-Implant Interface Biology Foreign Body Reaction and Periprosthetic Osteolysis in Artificial Hip Joints

  2009cites this paper
• Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.

  2009cites this paper
• Biomarkers in equine synovial fluid and serum for the diagnosis of joint diseases

  2009cites this paper
• Degenerative changes of the interface membrane as a possible reason for prosthesis loosening.

  2008cites this paper
• Wear particles and osteolysis

  2008cites this paper
• Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.

  2006cites this paper
• The development of a small animal model of wear debris induced osteolysis.

  2006cites this paper
• Wear particulate and osteolysis.

  2005cites this paper
• Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study.

  2005cites this paper
• Hydroxy apatite microspheres enhance gap junctional intercellular communication of human osteoblasts composed of connexin 43 and 45.

  2005cites this paper
• Tenascin‐C levels in pseudosynovial fluid of loose hip prostheses

  2005cites this paper
• Human Motion and Its Relevance to Wear and Failure in Total Knee Arthroplasty

  2005cites this paper
• Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.

  2004cites this paper
• Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.

  2004cites this paper
• An experimental animal model of aseptic loosening of hip prostheses in sheep to study early biochemical changes at the interface membrane

  2004influential citation
• Foreign Body Reaction and Periprosthetic Osteolysis in Artificial Hip Joints ― ―

  2003cites this paper
• Role of Extracellular Matrix Remodeling in Advanced Biocompatibility

  2003cites this paper
• Biocompatibility of Various Kinds of Polymer Microspheres Estimated from Their Effect on Gap Junctional Intercellular Communication of Fibroblasts

  2002cites this paper
• Studies on in vitro evaluation for the biocompatibility of various biomaterials: inhibitory activity of various kinds of polymer microspheres on metabolic cooperation.

  2001cites this paper
• Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.

  2001cites this paper
• High‐Turnover Periprosthetic Bone Remodeling and Immature Bone Formation Around Loose Cemented Total Hip Joints

  2001cites this paper
• Osteoprotegerin inhibits in vitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty.

  2001cites this paper
• Bone-Implant Interface Biology

  2001cites this paper
• High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.

  2000cites this paper
• Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints.

  2000cites this paper
• Proteinases in bone resorption: obvious and less obvious roles.

  2000cites this paper